A new report from Advantage Solutions and Daymon reveals that 82% of consumers intend to purchase private brands during the 2026 holiday season. The report highlights how shoppers are balancing tighter budgets with the desire to celebrate, favoring private brands for their value and quality. Seasonal flavors and wellness trends are also shaping buying habits, with many consumers seeking to combine indulgence with healthier choices. Retailers are encouraged to innovate with private brand offerings to meet evolving consumer expectations and capitalize on growing demand beyond food categories.
Most consumers planning to purchase private brands this holiday season, here is Pluang's Consumer Staples sector snapshot as of Nov 12, 2026 20:21 WIB: Out of 63 priced US stocks, 41 rose and 18 fell today. Notable movers include MDLZ at USD 67.29 with a 0.88% increase and 100% buy order activity, JBS at USD 12.35 down 0.80% with 81% sell orders, and EL at USD 111.43 down 0.80% with 100% buy orders. Typical hold times range from 6 to 124 days among these stocks.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
